drugset / Trial / NCT06020352
The Efficacy and Safety of KN046 Combined With Axitinib
NaSingle-groupOpen-labelTreatment
Summary
Evaluation of the efficacy of KN046 combined with acitinib as a neoadjuvant therapy for resectable NSCLC through primary pathological response rate and surgical resection rate
Timeline
- Start
- 2023-08-25
- Primary completion
- 2025-07-01
- Completion
- 2025-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Axitinib | Small molecule | — | — |
| Subject | ERFONRILIMAB | Monoclonal antibody | — | — |